Further, markers of neurodegeneration and glial activation were elevated in p-tau-181/ β-amyloid1-42 positive subjects with mild cognitive impairment (MCI)/dementia and neurodegenerative proteins increased with clinical severity and predicted a cognitive decline in this group [10–12]. Here, MAPT is linked to Mental deterioration.